Literature DB >> 4655271

The ring test: a quantitative method for assessing the 'cataleptic' effect of cannabis in mice.

R G Pertwee.   

Abstract

1. A bioassay for cannabis, called the ring test, has been developed in which the percentage of the total time spent on a horizontal wire ring during which a mouse remains completely immobile is recorded.2. The effect of cannabis on mobility is a dose-related, graded response.3. Threshold doses of cannabis extract are 12.5 mg/kg when injected intravenously, and 100 mg/kg when injected intraperitoneally or subcutaneously.4. The method provides a measure of the ;cataleptic' effect of cannabis. Chlorpromazine in doses of 1 mg/kg upwards also produces the effect but barbitone does not.5. It is concluded that Delta(1)-tetrahydrocannabinol (Delta(1)-THC) is largely responsible for the effect of cannabis extract on mobility; the potency ratio of Delta(1)-THC to cannabis extract is between 10 and 20. Delta(1)-Tetrahydrocannabidivarol (Delta(1)-THD) also affects mobility but is less active than Delta(1)-THC. Cannabidiol has no effect when injected intraperitoneally in doses up to 100 mg/kg.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4655271      PMCID: PMC1666359          DOI: 10.1111/j.1476-5381.1972.tb06900.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  12 in total

1.  Rapid depletion of adrenal epinephrine and elevation of telencephalic serotonin by (-)-trans- 9 -tetrahydrocannabinol in mice.

Authors:  B L Welch; A S Welch; F S Messiha; H J Berger
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1971-05

2.  Pharmacology of some marijuana constituents and 2 heterocyclic analogues.

Authors:  W L Dewey; L S Harris; J F Howes; J S Kennedy; F E Granchelli; H G Pars; R K Razdan
Journal:  Nature       Date:  1970-06-27       Impact factor: 49.962

3.  Preliminary experiments on the chemistry and pharmacology of cannabis.

Authors:  E W Gill; W D Paton; R G Pertwee
Journal:  Nature       Date:  1970-10-10       Impact factor: 49.962

4.  Structure activity relationship of four tetrahydrocannabinols and the pharmacological activity of five semi-purified extracts of Cannabis sativa.

Authors:  E A Carlini; M Santos; U Claussen; D Bieniek; F Korte
Journal:  Psychopharmacologia       Date:  1970-08-19

5.  Effects of (--) delta-9-trans-tetrahydrocannabinol and a synthetic derivative on maze performance of rats.

Authors:  E A Carlini; A Hamaoui; D Bieniek; F Korte
Journal:  Pharmacology       Date:  1970       Impact factor: 2.547

6.  Psychopharmacological activity of the active constituents of hashish and some related cannabinoids.

Authors:  Y Grunfeld; H Edery
Journal:  Psychopharmacologia       Date:  1969

7.  Effects of some tetrahydrocannabinols on hexobarbital sleeping time and amphetamine induced hyperactivity in mice.

Authors:  J C Garriott; L J King; R B Forney; F W Hughes
Journal:  Life Sci       Date:  1967-10-01       Impact factor: 5.037

8.  1-delta9-tetrahydrocannabinol: neurochemical and behavioral effects in the mouse.

Authors:  D Holtzman; R A Lovell; J H Jaffe; D X Freedman
Journal:  Science       Date:  1969-03-28       Impact factor: 47.728

9.  Behavioral effects in monkeys of racemates of two biologically active marijuana constituents.

Authors:  C L Scheckel; E Boff; P Dahlen; T Smart
Journal:  Science       Date:  1968-06-28       Impact factor: 47.728

10.  Activity of delta8- and delta9-tetrahydrocannabinol and related compounds in the mouse.

Authors:  H D Christensen; R I Freudenthal; J T Gidley; R Rosenfeld; G Boegli; L Testino; D R Brine; C G Pitt; M E Wall
Journal:  Science       Date:  1971-04-09       Impact factor: 47.728

View more
  52 in total

1.  Chromenopyrazoles: non-psychoactive and selective CB₁ cannabinoid agonists with peripheral antinociceptive properties.

Authors:  Jose Cumella; Laura Hernández-Folgado; Rocio Girón; Eva Sánchez; Paula Morales; Dow P Hurst; Maria Gómez-Cañas; Maria Gómez-Ruiz; Diana C G A Pinto; Pilar Goya; Patricia H Reggio; María Isabel Martin; Javier Fernández-Ruiz; Artur M S Silva; Nadine Jagerovic
Journal:  ChemMedChem       Date:  2012-02-02       Impact factor: 3.466

2.  Inhalation exposure to smoke from synthetic "marijuana" produces potent cannabimimetic effects in mice.

Authors:  Jason M Wiebelhaus; Justin L Poklis; Alphonse Poklis; Robert E Vann; Aron H Lichtman; Laura E Wise
Journal:  Drug Alcohol Depend       Date:  2012-07-07       Impact factor: 4.492

3.  Sphingosine-1-phosphate receptors mediate neuromodulatory functions in the CNS.

Authors:  Laura J Sim-Selley; Paulette B Goforth; Mba U Mba; Timothy L Macdonald; Kevin R Lynch; Sheldon Milstien; Sarah Spiegel; Leslie S Satin; Sandra P Welch; Dana E Selley
Journal:  J Neurochem       Date:  2009-05-31       Impact factor: 5.372

Review 4.  "Herbal incense": designer drug blends as cannabimimetics and their assessment by drug discrimination and other in vivo bioassays.

Authors:  Torbjörn U C Järbe; Roger S Gifford
Journal:  Life Sci       Date:  2013-07-25       Impact factor: 5.037

5.  CB1 Knockout Mice Unveil Sustained CB2-Mediated Antiallodynic Effects of the Mixed CB1/CB2 Agonist CP55,940 in a Mouse Model of Paclitaxel-Induced Neuropathic Pain.

Authors:  Liting Deng; Benjamin L Cornett; Ken Mackie; Andrea G Hohmann
Journal:  Mol Pharmacol       Date:  2015-04-22       Impact factor: 4.436

6.  Stress by restraining potentiates morphine catalepsy in rats.

Authors:  S K Bhattacharya; S S Parmar
Journal:  Experientia       Date:  1985-12-15

7.  Resolution of inflammation by N-arachidonoylglycine.

Authors:  Sumner H Burstein; Catherine A McQuain; Alonzo H Ross; Rebecca A Salmonsen; Robert E Zurier
Journal:  J Cell Biochem       Date:  2011-11       Impact factor: 4.429

8.  β-arrestin2 regulates cannabinoid CB1 receptor signaling and adaptation in a central nervous system region-dependent manner.

Authors:  Peter T Nguyen; Cullen L Schmid; Kirsten M Raehal; Dana E Selley; Laura M Bohn; Laura J Sim-Selley
Journal:  Biol Psychiatry       Date:  2012-01-20       Impact factor: 13.382

9.  Biochanin A, a naturally occurring inhibitor of fatty acid amide hydrolase.

Authors:  L Thors; J J Burston; B J Alter; M K McKinney; B F Cravatt; R A Ross; R G Pertwee; R W Gereau; J L Wiley; C J Fowler
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

10.  Cannabinoids ameliorate pain and reduce disease pathology in cerulein-induced acute pancreatitis.

Authors:  Christoph W Michalski; Tamara Laukert; Danguole Sauliunaite; Pál Pacher; Frank Bergmann; Nitin Agarwal; Yun Su; Thomas Giese; Nathalia A Giese; Sándor Bátkai; Helmut Friess; Rohini Kuner
Journal:  Gastroenterology       Date:  2007-02-21       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.